Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition
Corresponding Author
Shingo Yamamoto
Department of Urology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
Correspondence: Shingo Yamamoto M.D., Ph.D., Department of Urology, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan. Email: [email protected]Search for more papers by this authorKatsumi Shigemura
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
Search for more papers by this authorHiroshi Kiyota
Department of Urology, Jikei University, Tokyo, Japan
Search for more papers by this authorKoichiro Wada
Department of Urology, Okayama University Hospital, Okayama, Kagawa, Japan
Search for more papers by this authorHiroshi Hayami
Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorMitsuru Yasuda
Department of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan
Search for more papers by this authorSatoshi Takahashi
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
Search for more papers by this authorKiyohito Ishikawa
Department of Urology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
Search for more papers by this authorRyoichi Hamasuna
Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Search for more papers by this authorSoichi Arakawa
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
Search for more papers by this authorTetsuro Matsumoto
Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Search for more papers by this authorthe Japanese Research Group for UTI
Search for more papers by this authorCorresponding Author
Shingo Yamamoto
Department of Urology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
Correspondence: Shingo Yamamoto M.D., Ph.D., Department of Urology, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan. Email: [email protected]Search for more papers by this authorKatsumi Shigemura
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
Search for more papers by this authorHiroshi Kiyota
Department of Urology, Jikei University, Tokyo, Japan
Search for more papers by this authorKoichiro Wada
Department of Urology, Okayama University Hospital, Okayama, Kagawa, Japan
Search for more papers by this authorHiroshi Hayami
Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorMitsuru Yasuda
Department of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan
Search for more papers by this authorSatoshi Takahashi
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
Search for more papers by this authorKiyohito Ishikawa
Department of Urology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
Search for more papers by this authorRyoichi Hamasuna
Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Search for more papers by this authorSoichi Arakawa
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
Search for more papers by this authorTetsuro Matsumoto
Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Search for more papers by this authorthe Japanese Research Group for UTI
Search for more papers by this authorAbstract
After publication of the initial version of the Japanese guidelines for urological surgery in 2007, new surgical techniques have been introduced. Furthermore, several important issues, such as criteria for use of single-dose antimicrobial prophylaxis and control of hospitalized infection, were also established, which led to alterations of the methods used for antimicrobial prophylaxis as well as perioperative management. The purpose of antimicrobial prophylaxis is to protect the surgical wound from contamination by normal bacterial flora. Antimicrobial prophylaxis should be based on penicillins with beta-lactamase inhibitors, or first- or second-generation cephalosporins, though penicillins without beta-lactamase inhibitors should not be prescribed because of the high prevalence of antimicrobial resistance. As an adequate intratissue concentration of the antimicrobial at the surgical site should be accomplished by the time of initiation of surgery, antimicrobial prophylaxis should be started up to 30 min before beginning the operation. Antimicrobial prophylaxis should be terminated within 24 h in clean and clean-contaminated surgery, and within 2 days of surgery using the bowels, because a longer duration is a risk factor for surgical site infection development. Importantly, possible risk factors for surgical site infections include the antimicrobial prophylaxis methodology used as well as others, such as duration of preoperative hospitalization, hand washing, the American Society of Anesthesiologists score, diabetes and smoking history. These guidelines are to be applied only for preoperatively non-infected low-risk patients. In cases with preoperative infection or bacteriuria that can cause a surgical site infection or urinary tract infection after surgery, patients must receive adequate preoperative treatment based on the individual situation.
Supporting Information
Filename | Description |
---|---|
iju13161-sup-0001-TableS1.docxWord document, 12.7 KB | Table S1. Evidence level (EL) and recommendation grade (RG) adopted to this guideline. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 1999; 1999: 250–78.
- 2Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K; Japanese Society of UTI Cooperative Study Group (Chairman; Tetsuro Matsumoto). Japanese guidelines for prevention of perioperative infections in urological field. Int. J. Urol. 2007; 14: 890–909.
- 3Grabe M, Bjerklund-Johansen TE, Botto H et al. Guidelines on urological infections. 2012. [Cited 2 Aug 2016.] Available from URL: https://uroweb.org/wp-content/uploads/17_Urological-infections_LR-II.pdf
- 4Wolf JS Jr, Bennett CJ, Dmochowski RR et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J. Urol. 2008; 179: 1379–90.
- 5Ishikawa K, Hamasuna R, Uehara S et al. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J. Infect. Chemother. 2015; 21: 623–33.
- 6Koch CG, Li L, Hixson E et al. Is it time to refine? An exploration and simulation of optimal antimicrobial timing in general surgery. Am. Coll. Surg. 2013; 217: 628–35.
- 7Togo Y, Tanaka S, Kanematsu A et al. Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study. J. Infect. Chemother. 2013; 19: 1093–101.
- 8McDonald M, Grabsch E, Marshall C, Forbes A. Single versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust. N. Z. J. Surg. 1998; 68: 388–96.
- 9Ho VP, Barie PS, Stein SL et al. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery. Surg. Infect. (Larchmt) 2011; 12: 255–60.
- 10Güenaga KF, Matos D, Wille-Jørgensen P. Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst. Rev. 2011; 9: CD001544.
- 11Cao F, Li J, Li F. Mechanical bowel preparation for elective colorectal surgery: updated systematic review and meta-analysis. Int. J. Colorectal Dis. 2012; 27: 803–10.
- 12Wada K, Uehara S, Kira S et al. Prospective multi-institutional analysis according to the “Japanese guidelines for prevention of perioperative infections in urological field.” Nihon Hinyokika Gakkai Zasshi 2013; 104: 505–12. (In Japanese.)
- 13Johnson DC, Nielsen ME, Matthews J et al. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int. 2014; 114: 221–8.
- 14Yamamoto S, Kunishima Y, Kanamaru S et al. A multi-center prospective study for antibiotic prophylaxis to prevent perioperative infections in urologic surgery. Hinyokika Kiyo 2004; 50: 673–83. (In Japanese.)
- 15Tanaka K, Arakawa S, Miura T et al. Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy. J. Infect. Chemother. 2012; 18: 175–9.
- 16Shigemura K, Tanaka K, Matsumoto M et al. Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary Antibiotic dosing for infants and neonates. J. Infect. Chemother. 2012; 18: 479–84.
- 17Hashimoto J, Takahashi S, Kurimura Y, Takeyama K, Kunishima Y, Tsukamoto T. Clinical relevance of single administration of prophylactic antimicrobial agents against febrile evnets after removal of ureteral stents for patients with urinary diversion or reconstruction. Int. J. Urol. 2010; 17: 163–6.
- 18 Japanese Society of Endourology & ESWL. Guidelines for urological laparoscopic surgeries. Jpn. Endourol. ESWL. 2008; 21: 1–70.
- 19George AK, Srinvasan AK, Cho J, Sadek MA, Kavoussi LR. Surgical site infection rates following laparoscopic urological procedures. J. Urol. 2011; 185: 1289–93.
- 20Sato Y. Antimicrobial therapy in children (including neonates). Antibiot. Chemother. 2003; 19: 571–82. (In Japanese.)
- 21Yamamoto S, Kanamaru S, Ogawa O et al. Questionnaire survey on the theory of antimicrobial prophylaxis in urologic surgery. Hinyokika Kiyo 2004; 50: 779–86. (In Japanese.)
- 22Yamamoto S, Mitsui Y, Ueda Y et al. Assessment of single-dose regimen for antimicrobial prophylaxis to prevent perioperative infection in urologic surgery. Hinyokika Kiyo 2008; 54: 587–91. (In Japanese.)
- 23Shigemura K, Arakawa S, Yamashita M, Yasufuku T, Fujisawa M. Surgical site infection may be reduced by shorter duration of prophylactic antibiotic medication in urological surgeries. Jpn. J. Infect. Dis. 2009; 62: 440–3.
- 24Dellinger EP. Prophylactic antibiotics: administration and timing before operation are more important than administration after operation. Clin. Infect. Dis. 2007; 44: 928–30.
- 25Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993; 44: 221–36.
- 26Wszoła M, Kwiatkowski A, Ostaszewska A et al. Surgical site infections after kidney transplantation – where do we stand now? Transplantation 2013; 95: 878–82.
- 27Muñoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin. Infect. Dis. 2011; 33: S53–7.
- 28Ramos A, Asensio A, Muñez E et al. Incisional surgical site infection in kidney transplantation. Urology 2008; 72: 119–23.
- 29Laftavi MR, Rostami R, Patel S et al. Universal perioperative antimicrobial prophylaxis is not necessary in kidney transplantation. Clin. Transplant. 2012; 26: 437–42.
- 30Orlando G, Manzia TM, Sorge R et al. One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Surgery 2014; 57: 104–10.
- 31Bratzler DW, Dellinger EP, Olsen KM et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am. J. Health Syst. Pharm. 2013; 70: 195–283.
- 32Soave R. Prophylaxis strategies for solid-organ transplantation. Clin. Infect. Dis. 2001; 33: S26–31.
- 33Gasser TC, Wisard M, Frei R. Oral fleroxacin prophylaxis in transurethral surgery. J. Urol. 1996; 156: 146–8.
- 34Savoca G, Raber M, Lissiani A et al. Comparison of single preoperative oral rufloxacin versus perioperative ciprofloxacin as prophylactic agents in transurethral surgery. Arch. Ital. Urol. Androl. 2000; 72: 15–20.
- 35Alsaywid BS, Smith GH. Antibiotic prophylaxis for transurethral urological surgeries: Systematic review. Urol. Ann. 2013; 5: 61–74.
- 36Yokoyama M, Fujii Y, Yoshida S et al. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int. J. Urol. 2009; 16: 61–3.
- 37Berry A, Barratt A. Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis. J. Urol. 2002; 167(2 Pt 1): 571–7.
- 38Qiang W, Jianchen W, MacDonald R, Monga M, Wilt TJ. Antimicrobial prophylaxis for transuretheral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml; a systematic review. J. Urol. 2005; 173: 1175–81.
- 39Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG; Working Group “Urological Infections” of German Society of Urology. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur. Urol. 2005; 47: 549–56.
- 40Ishikawa K, Maruyama T, Kusaka M, Shiroki R, Hoshinaga K. The state of antimicrobial prophylaxis for holmium laser enucleation of the prostate: HoLEP and the results of a questionnaire survey. Hinyokika Kiyo 2011; 57: 539–43. (In Japanese.)
- 41Sohn DW, Kim SW, Hong CG, Yoon BI, Ha US, Cho YH. Risk factors of infectious complication after ureteroscopic procedures of the upper urinary tract. J. Infect. Chemother. 2013; 19: 1102–8.
- 42Matsumoto M, Shigemura K, Yamamichi F et al. Prevention of infectious complication and its risk factors after urological procedures of the upper urinary tract. Urol. Int. 2012; 88: 43–7.
- 43Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology 2003; 62: 214–7.
- 44Ozgur BC, Ekıcı M, Yuceturk CN, Bayrak O. Bacterial colonization of double J stents and bacteriuria frequency. Kaohsiung J. Med. Sci. 2013; 29: 658–61.
- 45Lu Y, Tianyong F, Ping H, Liangren L, Haichao Y, Qiang W. Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: a systematic review and meta-analysis. J. Urol. 2012; 188: 441–8.
- 46Shen P, Jiang M, Yang J et al. Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J. Urol. 2011; 186: 1328–35.
- 47Fujita K, Mizuno T, Ushiyama T et al. Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy. Int. J. Urol. 2000; 7: 224–30.
- 48Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur. Urol. 2006; 50: 981–90.
- 49Shigeta M, Yamasaki A, Hayashi M. A clinical study on upper urinary tract calculi treated with extracorporeal shock wave lithotripsy (ESWL) monotherapy, with regard to bacteriuria before ESWL treatment. Nihon Hinyokika Gakkai Zasshi 1993; 84: 866–72.
- 50Dinçel C, Ozdiler E, Ozenci H, Tazici N, Koşar A. Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types. J. Endourol. 1998; 12: 1–3.
- 51Charton M, Vallancien G, Veillon B, Brisset JM. Urinary tract infection in percutaneous surgery for renal calculi. J. Urol. 1986; 135: 15–7.
- 52Doğan HS, Sahin A, Cetinkaya Y, Akdoğan B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J. Endourol. 2002; 16: 649–53.
- 53Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int. 2006; 98: 1075–9.
- 54Bag S, Kumar S, Taneja N, Sharma V, Mandal AK, Singh SK. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology 2011; 77: 45–9.
- 55Knopf HJ, Graff HJ, Schulze H. Perioperative antibiotic prophylaxis in ureteroscopic stone removal. Eur. Urol. 2003; 44: 115–8.
- 56Sullivan NM, Sutter VL, Mims MM, Marsh VH, Finegold SM. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J. Infect. Dis. 1973; 127: 49–55.
- 57Quintiliani R, Klimek J, Cunha BA, Maderzo EG. Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences. Postgrad. Med. J. 1978; 54: 668–71.
- 58Bavetta S, Olsha O, Fenely J. Spreading sepsis by cystoscopy. Postgrad. Med. J. 1990; 66: 34–5.
- 59 American Urological Association; American Academy of Orthopaedic Surgeons. Advisory Statement: antibiotic prophylaxis for urological patients with total joint replacements. J. Urol. 2003; 169: 1796–7.
- 60Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur. Urol. 2008; 54: 1270–86.
- 61García-Perdomo HA, López H, Carbonell J et al. Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: a randomized clinical trial. World J. Urol. 2013; 31: 1433–9.
- 62Herr HW. Should antibiotics be given prior to outpatient cystoscopy? A plea to urologists to practice antibiotic stewardship. Eur. Urol. 2014; 65: 839–42.
- 63Chang WC, Hung YC, Li TC, Yang TC, Chen HY, Lin CC. Short course of prophylactic antibiotics in laparoscopically assisted vaginal hysterectomy. J. Reprod. Med. 2005; 50: 524–8.
- 64Southwell-Keely JP, Russo RR, March L, Cumming R, Cameron I, Brnabic AJ. Antibiotic prophylaxis in hip fracture surgery: a metaanalysis. Clin. Orthop. Relat. Res. 2004; 419: 179–84.
- 65Bratzler DW, Houck PM; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 2005; 189: 395–404.
- 66Abouassaly R, Angermeier KW, Montague DK. Risk of infection with an antibiotic coated penile prosthesis at device replacement for mechanical failure. J. Urol. 2006; 176: 2471–3.
- 67Mandava SH, Serefoglu EC, Freier MT, Wilson SK, Hellstrom WJ. Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J. Urol. 2012; 188: 1855–60.
- 68Mulcahy JJ, Carson CC 3rd. Long-term infection rates in diabetic patients implanted with antibiotic-impregnated versus nonimpregnated inflatable penile prostheses: 7-year outcomes. Eur. Urol. 2011; 60: 167–72.
- 69Taoka R, Togo Y, Kubo T et al. Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study. J. Infect. Chemother. 2013; 19: 926–30.
- 70Dicker AP, Figura AT, Waterman FM, Valicenti RK, Strup SE, Gomella LG. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech. Urol. 2000; 6: 104–8.
- 71Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pépin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur. Urol. 2012; 62: 453–9.
- 72Hasegawa T, Shimomura T, Yamada H et al. Fatal septic shock caused by transrectal needle biopsy of the prostate: a case report. J. Japan. Assoc. Infect. Dis. 2002; 76: 893–7.
- 73Togo Y, Kubo T, Taoka R et al. Occurrence of infection following prostate biopsy procedures in Japan. Japanese Research Group for Urinary Tract Infection (JRGU) – A multi-center retrospective study. J. Infect. Chemother. 2014; 20: 232–7.
- 74Kato R, Suzuki Y, Matsuura T et al. Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy. Hinyokika Kiyo 2010; 56: 453–6.
- 75Ozden E, Bostanci Y, Yakupoglu KY et al. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 2009; 74: 119–23.
- 76Sabbagh R, McCormack M, Péloquin F et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can. J Urol. 2004; 11: 2216–9.
- 77Shigemura K, Tanaka K, Yasuda M et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J. Urol. 2005; 23: 356–60.
- 78Schaeffer AJ, Montorsi F, Scattoni V et al. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int. 2007; 100: 51–7.
- 79Batura D, Rao G, Nielsen PB, Charlett A. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int. 2011; 107: 760–4.
- 80Shigemura K, Matsumoto M, Tanaka K, Yamashita M, Arakawa S, Fujisawa M. Efficacy of combination use of beta-lactamase inhibitor with penicillin and fluoroquinolones for antibiotic prophylaxis in transrectal prostate biopsy. Korean J. Urol. 2011; 52: 289–92.
- 81Yasuda M, Nakane K, Yamada Y et al. Clinical effectiveness and safety of tazobactam/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy. J. Infect. Chemother. 2014; 20: 631–4.
- 82Li CK, Tong BC, You JH. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy. Int. J. Infect. Dis. 2015; 43: 7–12.
- 83Summers SJ, Patel DP, Hamilton BD et al. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectalprostate biopsy. World J. Urol. 2015; 33: 2001–7.
- 84Gottesman T, Yossepowich O, Harari-Schwartz O, Tsivian A, Idler J, Dan M. The value of rectal cultures in treatment of sepsis following post-transrectal ultrasound-guided prostate biopsy. Urol. Int. 2015; 95: 177–82.
- 85Petrowsky H, Demartines N, Rousson V, Clavien PA. Evidence-based value of prophylactic drainage in gastrointestinal surgery. Ann. Surg. 2004; 240: 1074–85.
- 86Utsumi M, Shimizu J, Miyamoto A et al. Age as an independent risk factor for surgical site infections in a large gastrointestinal surgery cohort in Japan. J. Hosp. Infect. 2010; 75: 183–7.
- 87Abaza R, Prall D. Drain placement can be safely omitted after the majority of robotic partial nephrectomies. J. Urol. 2013; 189: 823–7.
- 88Moro ML, Carrieri MP, Tozzi AE, Lana S, Greco D. Risk factors for surgical wound infections in clean surgery: a multicenter study. Italian PRINOS Study Group. Ann. Ital. Chir. 1996; 67: 13–9.
- 89Drinkwater CJ, Neil MJ. Optimal timing of wound drain removal following tota joint arthroplasty. J. Arthroplasty 1995; 10: 185–9.
- 90Vilar-Compte D, Mohar A, Sandoval S, de la Rosa M, Gordillo P, Volkow P. Surgical site infections at the National Cancer Institute in Mexico: a case-control study. Am. J. Infect. Control 2000; 28: 14–20.
- 91Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst. Rev. 2007; 18: CD001825.
- 92Clifton R, Haleem S, McKee A, Parker MJ. Closed suction surgical wound drainage after hip fracture surgery: a systematic review and meta-analysis of randomized controlled trials. Int. Orthop. 2008; 32: 723–7.
- 93Vermeulen H, Storm-Versloot MN, Busch OR, Ubbink DT. Nasogastric intubation after abdominal surgery: a meta-analysis of recent literature. Arch. Surg. 2006; 141: 307–14.
- 94Yang Z, Zheng Q, Wang Z. Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Br. J. Surg. 2008; 95: 809–16.